Literature DB >> 19788026

11q terminal deletion disorder and common variable immunodeficiency.

Gregory Puglisi, Mahesh A Netravali, Andrew J MacGinnitie, Vincent R Bonagura.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19788026     DOI： 10.1016/S1081-1206(10)60192-5

Source DB:  PubMed          Journal:  Ann Allergy Asthma Immunol        ISSN： 1081-1206            Impact factor:   6.347


× No keyword cloud information.
  4 in total

1.  Patients with Chromosome 11q Deletions Are Characterized by Inborn Errors of Immunity Involving both B and T Lymphocytes.

Authors:  Elise J Huisman; A Rick Brooimans; Samone Mayer; Marieke Joosten; Louis de Bont; Mariëlle Dekker; Elisabeth L M Rammeloo; Frans J Smiers; P Martin van Hagen; C Michel Zwaan; Masja de Haas; Marjon H Cnossen; Virgil A S H Dalm
Journal:  J Clin Immunol       Date:  2022-06-28       Impact factor: 8.317

2.  Immune Deficiency in Jacobsen Syndrome: Molecular and Phenotypic Characterization.

Authors:  Raquel Rodríguez-López; Fátima Gimeno-Ferrer; Elena Montesinos; Irene Ferrer-Bolufer; Carola Guzmán Luján; David Albuquerque; Carolina Monzó Cataluña; Virginia Ballesteros; Monserrat Aleu Pérez-Gramunt
Journal:  Genes (Basel)       Date:  2021-07-31       Impact factor: 4.096

3.  Terminal deletion of 11q with significant late-onset combined immune deficiency.

Authors:  Mikko Seppänen; Hannele Koillinen; Satu Mustjoki; Mölkänen Tomi; Kathleen E Sullivan
Journal:  J Clin Immunol       Date:  2014-01       Impact factor: 8.317

4.  The 11q Terminal Deletion Disorder Jacobsen Syndrome is a Syndromic Primary Immunodeficiency.

Authors:  Virgil A S H Dalm; Gertjan J A Driessen; Barbara H Barendregt; Petrus M van Hagen; Mirjam van der Burg
Journal:  J Clin Immunol       Date:  2015-11-14       Impact factor: 8.317
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.